Skip to content

Dr. Rupert Vessey

  • DPhil
  • Senior Vice President - Respiratory and Immunology Franchise
  • Merck Research Laboratories

    Research interests

    PharmacogenomicsPharmacodynamicsImmunologyPharmacogeneticsPersonalized MedicineDrug DiscoveryVaccinesBiomarkersPharmaceuticalsClinical DevelopmentTranslational Medicine

    About

    Dr. Rupert Vessey- Head of Early Development and Discovery Sciences Currently Dr. Rupert Vessey functions as head of early development and discovery sciences with Merck Research Laboratories, a research and development healthcare company. Dr. Vessey has been in the pharmaceutical industry since 1997, having begun his tenure working for GlaxoSmithKline (GSK) in the United Kingdom. During his time at GSK, he focused on drug discovery, experimental medicine, and early clinical development and contributed to projects involving DNA vaccines and monoclonal antibodies. Over the course of his subsequent career with Merck, Dr. Rupert Vessey has served in roles such as vice president of drug discovery and site head for Boston and Kenilworth. A Fellow of the Royal College of Physicians in London, Dr. Rupert Vessey completed his education and clinical training in the United Kingdom. He earned his M.D. from Oxford University and his PhD from the Institute for Molecular Medicine. He also trained at the John Radcliffe Hospital and the National Hospital for Neurology and Neurosurgery, both in England.

    Professional experience

    Senior Vice President - Respiratory and Immunology Franchise

    Merck

    March 2011 - Present

    Vice President

    Merck

    September 2006 - March 2011(5 years)

    Education

    DPhil

    University of Oxford

    January 1994 - January 1997(3 years)

    MA - Molecular Immunology

    University of Oxford

    January 1988 - January 1990(2 years)